• レポートコード:MRC2110B019 • 出版社/出版日:Persistence Market Research / 2021年9月30日 • レポート形態:英文、PDF、345ページ • 納品方法:Eメール • 産業分類:バイオ |
Individual User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、トランスフォーミング成長因子の世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、需要分析・予測、価格分析・予測、製品別(アクチビン、骨形成タンパク質(BMP)、TGF-ベータタンパク質)分析、グレード別(GMP、非GMP)分析、用途別(腫瘍学研究、血液学研究、創傷治癒研究、皮膚科研究、心血管疾患・糖尿病)分析、エンドユーザー別(製薬・バイオテクノロジー企業、研究センター・学術研究所、CMO・CDMO)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・需要分析・予測 ・価格分析・予測 ・トランスフォーミング成長因子の世界市場規模:製品別(アクチビン、骨形成タンパク質(BMP)、TGF-ベータタンパク質) ・トランスフォーミング成長因子の世界市場規模:グレード別(GMP、非GMP) ・トランスフォーミング成長因子の世界市場規模:用途別(腫瘍学研究、血液学研究、創傷治癒研究、皮膚科研究、心血管疾患・糖尿病) ・トランスフォーミング成長因子の世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、研究センター・学術研究所、CMO・CDMO) ・トランスフォーミング成長因子の世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Transforming Growth Factor Market – Scope of Report
The latest publication by Persistence Market Research on the global transforming growth factor market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market.
The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for transforming growth factor products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the transforming growth factor market.
The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the transforming growth factor market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the transforming growth factor market offers information divided into five important segments – product, grade, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
[Product]
Activin
Bone Morphogenetic Proteins (BMPs)
TGF-beta Proteins
[Grade]
GMP Grade
NON-GMP Grade
[Application]
Oncology Research
Hematology Research
Wound Healing Research
Dermatology Research
Cardiovascular Disease & Diabetes
Cell Therapy and Ex Vivo Manufacturing
Others
[End User]
Pharmaceutical and Biotechnology Companies
Research Centers & Academic Institutes
CMOs and CDMOs
[Region]
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Form Innovation / Development Trends
4. Key Success Factors
4.1. Key Regulations
4.2. Key Promotional Strategies
4.3. Value Chain Analysis
4.4. Gross Margins Analysis
4.5. Key Regulation: FDA Drug Approval Process
4.6. Regulatory Scenario
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Global Cosmetic Procedures Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Growing Contract Research Activities
5.2.2. Technological Advancements in Cell Culture applications
5.2.3. Increasing funding in life science research
5.2.4. Adoption of Growth Factors in Cell therapy and Ex vivo manufacturing
5.2.5. Launch of New Product
5.2.6. Adoption of Growth Factors for oncology research
5.2.7. Growing Research and Academic Institutes
5.2.8. Increasing focus on oncology research
5.2.9. Increasing assay developments for drug discovery
5.2.10. Increasing Application in Regenerative Medicine
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis, by Country
6.5. 2021 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Transforming Growth Factor Market Demand (In Volume Units) Analysis 2016–2020 and Forecast, 2021–2031
7.1. Historical Market (Volume) Analysis, 2016–2020
7.2. Current and Future Market (Volume) Projections, 2021–2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Transforming Growth Factor Market – Pricing Analysis
8.1. Regional Pricing Analysis
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Transforming Growth Factor Market Demand Value (US$ Mn) Analysis 2016–2020 and Forecast, 2021–2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016–2020
9.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Transforming Growth Factor Market (US$ Mn) By Product, 2016–2020
10.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Product, 2021–2031
10.3.1. Activin
10.3.2. Bone Morphogenetic Proteins (BMPs)
10.3.3. TGF-beta Proteins
10.4. Market Attractiveness Analysis By Product
11. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Grade
11.1. Introduction / Key Findings
11.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Grade, 2016–2020
11.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Grade, 2021–2031
11.3.1. GMP Grade
11.3.2. NON-GMP Grade
11.4. Market Attractiveness Analysis By Grade
12. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, By Application
12.1. Introduction / Key Findings
12.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Application, 2016–2020
12.3. Current and Future Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Application, 2021–2031
12.3.1. Oncology Research
12.3.2. Hematology Research
12.3.3. Wound Healing Research
12.3.4. Dermatology Research
12.3.5. Cardiovascular Disease & Diabetes
12.3.6. Cell therapy and Ex vivo manufacturing
12.3.7. Others
12.4. Market Attractiveness Analysis By Application
13. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, by End User
13.1. Introduction
13.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By End User, 2016 – 2020
13.3. Current Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By End User, 2021 – 2031
13.3.1. Pharmaceutical and Biotechnology Companies
13.3.2. Research Centers & Academic Institutes
13.3.3. CMO and CDMO
13.4. Market Attractiveness Analysis By End User
14. Global Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031, by Region
14.1. Introduction
14.2. Historical Transforming Growth Factor Market (US$ Mn) Analysis By Region, 2016 – 2020
14.3. Current Transforming Growth Factor Market (US$ Mn) Analysis and Forecast By Region, 2021 – 2031
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
15.1. Introduction
15.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
15.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product
15.3.3. By Grade
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
16. Latin America Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
16.1. Introduction
16.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020
16.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Grade
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
17. Europe Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
17.1. Introduction
17.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
17.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Product
17.3.3. By Grade
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
18. South Asia Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
18.1. Introduction
18.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
18.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Thailand
18.3.1.3. Indonesia
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Grade
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
19. East Asia Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
19.1. Introduction
19.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By Grade
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
20. Oceania Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
20.1. Introduction
20.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020
20.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Grade
20.3.4. By Application
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Market Trends
20.6. Key Market Participants – Intensity Mapping
21. Middle East and Africa Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
21.1. Introduction
21.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2016–2020
21.3. Market Material (US$ Mn) Forecast By Market Taxonomy, 2021–2031
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. South Africa
21.3.1.4. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Grade
21.3.4. By Application
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.5. Market Trends
21.6. Key Market Participants – Intensity Mapping
22. Key & Emerging Countries Transforming Growth Factor Market Analysis 2016–2020 and Forecast 2021–2031
22.1. U.S. Transforming Growth Factor Market Analysis
22.1.1. By Product
22.1.2. By Grade
22.1.3. By Application
22.1.4. By End User
22.2. Canada Transforming Growth Factor Market Analysis
22.2.1. By Product
22.2.2. By Grade
22.2.3. By Application
22.2.4. By End User
22.3. By End User Brazil Transforming Growth Factor Market Analysis
22.3.1. By Product
22.3.2. By Grade
22.3.3. By Application
22.3.4. By End User
22.4. Mexico Transforming Growth Factor Market Analysis
22.4.1. By Product
22.4.2. By Grade
22.4.3. By Application
22.4.4. By End User
22.5. U.K. Transforming Growth Factor Market Analysis
22.5.1. By Product
22.5.2. By Grade
22.5.3. By Application
22.5.4. By End User
22.6. Germany Transforming Growth Factor Market Analysis
22.6.1. By Product
22.6.2. By Grade
22.6.3. By Application
22.6.4. By End User
22.7. France Transforming Growth Factor Market Analysis
22.7.1. By Product
22.7.2. By Grade
22.7.3. By Application
22.7.4. By End User
22.8. Italy Transforming Growth Factor Market Analysis
22.8.1. By Product
22.8.2. By Grade
22.8.3. By Application
22.8.4. By End User
22.9. Spain Transforming Growth Factor Market Analysis
22.9.1. By Product
22.9.2. By Grade
22.9.3. By Application
22.9.4. By End User
22.10. BENELUX Transforming Growth Factor Market Analysis
22.10.1. By Product
22.10.2. By Grade
22.10.3. By Application
22.10.4. By End User
22.11. Russia Transforming Growth Factor Market Analysis
22.11.1. By Product
22.11.2. By Grade
22.11.3. By Application
22.11.4. By End User
22.12. China Transforming Growth Factor Market Analysis
22.12.1. By Product
22.12.2. By Grade
22.12.3. By Application
22.12.4. By End User
22.13. Japan Transforming Growth Factor Market Analysis
22.13.1. By Product
22.13.2. By Grade
22.13.3. By Application
22.13.4. By End User
22.14. South Korea Transforming Growth Factor Market Analysis
22.14.1. By Product
22.14.2. By Grade
22.14.3. By Application
22.14.4. By End User
22.15. ASEAN Transforming Growth Factor Market Analysis
22.15.1. By Product
22.15.2. By Grade
22.15.3. By Application
22.15.4. By End User
22.16. Australia Transforming Growth Factor Market Analysis
22.16.1. By Product
22.16.2. By Grade
22.16.3. By Application
22.16.4. By End User
22.17. New Zealand Transforming Growth Factor Market Analysis
22.17.1. By Product
22.17.2. By Grade
22.17.3. By Application
22.17.4. By End User
22.18. GCC Countries Transforming Growth Factor Market Analysis
22.18.1. By Product
22.18.2. By Grade
22.18.3. By Application
22.18.4. By End User
22.19. South Africa Transforming Growth Factor Market Analysis
22.19.1. By Product
22.19.2. By Grade
22.19.3. By Application
22.19.4. By End User
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Concentration
23.3. Market Share Analysis of Top Players
23.4. Market Presence Analysis
23.4.1. Regional footprint of Players
23.4.2. Product foot print by Players
23.4.3. Channel Foot Print by Players
24. Competition Analysis
24.1. Competition Dashboard
24.2. Pricing Analysis by Competition
24.3. Competition Benchmarking
24.4. Competition Deep Dive
24.4.1. GE Healthcare
24.4.1.1. Overview
24.4.1.2. Product Portfolio
24.4.1.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.1.4. Sales Footprint
24.4.1.5. Strategy Overview
24.4.1.5.1. Marketing Strategy
24.4.1.5.2. Drug Strategy
24.4.1.5.3. Channel Strategy
24.4.2. Thermo Fisher Scientific
24.4.2.1. Overview
24.4.2.2. Product Portfolio
24.4.2.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.2.4. Sales Footprint
24.4.2.5. Strategy Overview
24.4.2.5.1. Marketing Strategy
24.4.2.5.2. Drug Strategy
24.4.2.5.3. Channel Strategy
24.4.3. Lonza Group AG
24.4.3.1. Overview
24.4.3.2. Product Portfolio
24.4.3.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.3.4. Sales Footprint
24.4.3.5. Strategy Overview
24.4.3.5.1. Marketing Strategy
24.4.3.5.2. Drug Strategy
24.4.3.5.3. Channel Strategy
24.4.4. Merck KGaA
24.4.4.1. Overview
24.4.4.2. Product Portfolio
24.4.4.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.4.4. Sales Footprint
24.4.4.5. Strategy Overview
24.4.4.5.1. Marketing Strategy
24.4.4.5.2. Drug Strategy
24.4.4.5.3. Channel Strategy
24.4.5. F. Hoffmann-La Roche Ltd
24.4.5.1. Overview
24.4.5.2. Product Portfolio
24.4.5.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.5.4. Sales Footprint
24.4.5.5. Strategy Overview
24.4.5.5.1. Marketing Strategy
24.4.5.5.2. Drug Strategy
24.4.5.5.3. Channel Strategy
24.4.6. Abcam plc.
24.4.6.1. Overview
24.4.6.2. Product Portfolio
24.4.6.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.6.4. Sales Footprint
24.4.6.5. Strategy Overview
24.4.6.5.1. Marketing Strategy
24.4.6.5.2. Drug Strategy
24.4.6.5.3. Channel Strategy
24.4.7. Bio-Techne.
24.4.7.1. Overview
24.4.7.2. Product Portfolio
24.4.7.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.7.4. Sales Footprint
24.4.7.5. Strategy Overview
24.4.7.5.1. Marketing Strategy
24.4.7.5.2. Drug Strategy
24.4.7.5.3. Channel Strategy
24.4.8. Sartorius CellGenix GmbH
24.4.8.1. Overview
24.4.8.2. Product Portfolio
24.4.8.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.8.4. Sales Footprint
24.4.8.5. Strategy Overview
24.4.8.5.1. Marketing Strategy
24.4.8.5.2. Drug Strategy
24.4.8.5.3. Channel Strategy
24.4.9. Proteintech Group, Inc.
24.4.9.1. Overview
24.4.9.2. Product Portfolio
24.4.9.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.9.4. Sales Footprint
24.4.9.5. Strategy Overview
24.4.9.5.1. Marketing Strategy
24.4.9.5.2. Drug Strategy
24.4.9.5.3. Channel Strategy
24.4.10. PeproTech Inc.
24.4.10.1. Overview
24.4.10.2. Product Portfolio
24.4.10.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.10.4. Sales Footprint
24.4.10.5. Strategy Overview
24.4.10.5.1. Marketing Strategy
24.4.10.5.2. Drug Strategy
24.4.10.5.3. Channel Strategy
24.4.11. Cell Signaling Technology, Inc.
24.4.11.1. Overview
24.4.11.2. Product Portfolio
24.4.11.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.11.4. Sales Footprint
24.4.11.5. Strategy Overview
24.4.11.5.1. Marketing Strategy
24.4.11.5.2. Drug Strategy
24.4.11.5.3. Channel Strategy
24.4.12. Meridian Bioscience Inc.
24.4.12.1. Overview
24.4.12.2. Product Portfolio
24.4.12.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.12.4. Sales Footprint
24.4.12.5. Strategy Overview
24.4.12.5.1. Marketing Strategy
24.4.12.5.2. Drug Strategy
24.4.12.5.3. Channel Strategy
24.4.13. Applied Biological Materials (abm), Inc.
24.4.13.1. Overview
24.4.13.2. Product Portfolio
24.4.13.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.13.4. Sales Footprint
24.4.13.5. Strategy Overview
24.4.13.5.1. Marketing Strategy
24.4.13.5.2. Drug Strategy
24.4.13.5.3. Channel Strategy
24.4.14. Akron Biotech
24.4.14.1. Overview
24.4.14.2. Product Portfolio
24.4.14.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.14.4. Sales Footprint
24.4.14.5. Strategy Overview
24.4.14.5.1. Marketing Strategy
24.4.14.5.2. Drug Strategy
24.4.14.5.3. Channel Strategy
24.4.15. Leadgene Biomedical, Inc
24.4.15.1. Overview
24.4.15.2. Product Portfolio
24.4.15.3. Profitability by Market Segments (Drug/Channel/Region)
24.4.15.4. Sales Footprint
24.4.15.5. Strategy Overview
24.4.15.5.1. Marketing Strategy
24.4.15.5.2. Drug Strategy
24.4.15.5.3. Channel Strategy
25. Assumptions and Acronyms Used
26. Research Methodology